Vitreous haemorrhage

  • 文章类型: Journal Article
    目的:探讨不同程度的玻璃体出血(VH)和钙化是否是晚期视网膜母细胞瘤(RB)患者摘除的危险因素。
    方法:高级RB由RB的国际分类(费城版本)定义。采用logistic回归模型对我院2017年1月至2022年6月诊断为D组和E组的视网膜母细胞瘤患者的基本信息进行回顾性分析。此外,进行了相关性分析,从多变量分析中排除VIF(方差膨胀因子)>10的变量。
    结果:总共223只诊断为RB的眼睛被纳入评估VH和钙化;其中,101(45.3%)眼经历VH,通过计算机断层扫描(CT)或B超检查发现182只(76.2%)眼肿瘤内钙化。92只眼睛(41.3%)摘除,其中67例(72.8%)有VH,68例(73.9%)钙化,两者均与摘除术显著相关(p<0.001*).其他临床危险因素,如角膜水肿,前房出血,治疗期间的高眼压和虹膜新生血管,与眼球摘除显著相关(p<0.001*)。多因素分析包括IIRC(眼内国际视网膜母细胞瘤分类),VH,治疗期间钙化和高眼压是眼球摘除的独立危险因素。
    结论:尽管发现了不同的RB潜在危险因素,关于哪些患者需要摘除,仍然存在重大争议,VH的程度各不相同。这样的眼睛需要仔细评估,适当的辅助治疗可以改善这些患者的预后。
    OBJECTIVE: To explore whether varying degrees of vitreous haemorrhage (VH) and calcification act as risk factors for enucleation in patients with advanced retinoblastoma (RB).
    METHODS: Advanced RB was defined by the international classification of RB (Philadelphia version). Basic information for retinoblastoma patients diagnosed as groups D and E in our hospital between January 2017 and June 2022 was reviewed by logistics regression models. Additionally, a correlation analysis was performed, excluding variables with a VIF (variance inflation factor) >10 from the multivariate analysis.
    RESULTS: A total of 223 eyes diagnosed with RB were included in assessing VH and calcification; of these, 101 (45.3%) eyes experienced VH, and 182 (76.2%) eyes were found to have calcification within the tumour through computed tomography (CT) or B-scan ultrasonography. Ninety-two eyes (41.3%) were enucleated, of which 67 (72.8%) had VH and 68 (73.9%) calcification, both of which were significantly relevant to enucleation (p < 0.001*). Other clinical risk factors, such as corneal edema, anterior chamber haemorrhage, high intraocular pressure during treatment and iris neovascularization, correlated significantly with enucleation (p < 0.001*). Multivariate analysis included IIRC (intraocular international retinoblastoma classification), VH, calcification and high intraocular pressure during treatment as independent risk factors for enucleation.
    CONCLUSIONS: Despite identifying different potential risk factors for RB, there remains significant controversy concerning which patients require enucleation, and the degree of VH varies. Such eyes need to be evaluated carefully, and management with appropriate adjuvant therapy may improve the outcome of these patients.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    背景:本研究旨在评估术前、术前和术后玻璃体腔注射康柏西普(IVC)对重度增生性糖尿病视网膜病变(PDR)的影响。
    方法:这是一个前瞻性的,比较和随机研究。本研究共纳入84例因严重PDR而接受玻璃体切除术的患者。将患者随机分为对照组(41只眼)和实验组(43只眼)。实验组患者在手术前和手术后接受辅助IVC注射,而对照组患者仅接受术前IVC注射。术后玻璃体出血(POVH)的发生率,确定最佳矫正视力(BCVA)和中央视网膜厚度(CRT)。
    结果:两组早期POVH的发生率有显著差异,但在3个月和6个月时,组间没有观察到显著差异。在实验组中,与对照组相比,术后1个月BCVA显著改善(p0.019).组间术后3个月和6个月的平均BCVA没有显着差异(p0.063和0.082)。术后1个月和3个月,实验组的CRT明显低于对照组(p0.037和0.041),但6个月时无显著差异(p0.894)。
    结论:在手术结束时额外注射IVC可改善严重PDR手术后早期的POVH和BCVA,但是这种好处在6个月时就不存在了。需要进一步的研究来研究玻璃体切除术结束时IVC的效果。
    背景:chictr.org.cn标识符:ChiCTR2200060735。追溯登记,注册日期:2022年6月9日。
    BACKGROUND: This study aimed to evaluate the effect of pre-operative versus pre-operative plus post-operative intravitreal conbercept (IVC) injection on severe proliferative diabetic retinopathy (PDR).
    METHODS: This was a prospective, comparative and randomised study. A total of 84 patients who underwent vitrectomy for severe PDR were included in this study. Patients were randomly divided into control (41 eyes) and experiment (43 eyes) groups. Patients in the experiment group received adjunctive pre-operative and post-operative IVC injection, whereas patients in the control group only received pre-operative IVC injection. The incidence of post-operative vitreous haemorrhage (POVH), best-corrected visual acuity (BCVA) and central retinal thickness (CRT) were determined.
    RESULTS: The incidence of early POVH was significantly different between the two groups, but no significant difference was observed between groups at 3 and 6 months. In the experiment group, the BCVA was significantly improved 1 month after surgery when compared with the control group (p 0.019). There was no marked difference in the mean post-operative BCVA at 3 and 6 months between groups (p 0.063 and 0.082). CRT was significantly lower in the experiment group than in the control group at 1 and 3 months after surgery (p 0.037 and 0.041), but there was no significant difference at 6 months (p 0.894).
    CONCLUSIONS: Additional IVC injected at the end of surgery improves the POVH and BCVA at the early stage after surgery in severe PDR, but this benefit is absent at 6 months. Further studies are needed to investigate the effect of IVC at the end of vitrectomy.
    BACKGROUND: chictr.org.cn identifier: ChiCTR2200060735. Retrospectively registered, register date: 9 June 2022.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Case Reports
    Macular tears rarely occur without trauma. Here, we describe a patient with vitreous haemorrhage, which was caused by an unusual giant macular tear secondary to existing branch retinal vein occlusion. A 60-year-old woman presented with vision loss in the right eye because of vitreous haemorrhage. She had a history of branch retinal vein occlusion and had been treated with retinal photocoagulation 3 years prior. As treatment for vitreous haemorrhage, the patient underwent 23-gauge pars plana vitrectomy combined with silicone oil tamponade. During the operation, a large jagged tear was observed in the macula. We presumed that stretching of the fibrous proliferating membrane secondary to branch retinal vein occlusion was responsible for the macular tear and vitreous haemorrhage. Eventually, the results of pars plana vitrectomy led to anatomical closure of the macular tear and partial restoration of visual acuity.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Sci-hub)

       PDF(Pubmed)

公众号